3171 results for «3241»

Filter By

3171 results

Combined valve interventions

28 Nov 2022 – From PCR London Valves 2022

Among the very interesting cases presented in this PCR LV 2022 session, watch the 1st case of TMVR and TTVR in a patient with the use of dedicated investigational devices, simultaneous transcatheter mitral and tricuspid approach in a patient with dextrocardia, or simultaneous mitral valve-in-valve, tricuspid...

Combined valve interventions

Challenging scenarios: bioprosthetic valve dysfunction

28 Nov 2022 – From PCR London Valves 2022

Consult this session to learn more about the different causes of bioprosthetic valve dysfunction and the best options (surgical, transcatheter or medical) for the management of patients with this kind of dysfunction, as well as to discover how valve design impacts on durability and what the future holds...

Challenging scenarios: bioprosthetic valve dysfunction

Mitral complications

28 Nov 2022 – From PCR London Valves 2022

Because we can all be confronted with unexpected complications, this session of PCR LV 2022 proposes to study 5 specific cases such as an early redo mitral transcatheter edge-to-edge repair after single leaflet detachment or an unexpected cause of worsening dyspnoea after edge-to-edge mitral repair.

Mitral complications

Optimal management of right ventricular pacing leads in patients with tricuspid regurgitation

28 Nov 2022 – From PCR London Valves 2022

Consult these presentations to learn more about the consequences of right ventricular pacing lead implantation on tricuspid valve function, the diagnosis and imaging assessment of lead-induced tricuspid regurgitation and the possible treatment options for patients with right ventricular pacing leads and significant tricuspid regurgitation.

Optimal management of right ventricular pacing leads in patients with tricuspid regurgitation

Transcatheter mitral valve interventions: clinical outcomes 2

28 Nov 2022 – From PCR London Valves 2022

This PCR LV 2022 session will enable you to discover outcomes of transcatheter edge-to-edge MVR in patients with right ventricle dysfunction, TEER for MR early after myocardial infarction, or a predictive selection of patients for TMVR, among others!

Transcatheter mitral valve interventions: clinical outcomes 2

TAVI: technical considerations

28 Nov 2022 – From PCR London Valves 2022

Consult this session on TAVI technical considerations to discover a selection of cases presented during PCR LV 2022: transseptal snaring as a bailout from valvuloplasty balloon entrapment within a self-expanding valve, severe thrombocytopenia and severe aortic stenosis, embolisation of a fully deployed Evolute valve due to chest...

TAVI: technical considerations

TAVI complications: Session 3

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover how to manage various TAVI complications: complex iliofemoral artery dissection following TAVI, ruptured TAVI balloon, displacement of the transcatheter aortic valve prosthesis, and much more!

TAVI complications: Session 3

Transcatheter mitral valve interventions: clinical outcomes 1

28 Nov 2022 – From PCR London Valves 2022

Consult this session on transcatheter mitral valve interventions to discover a selection of abstracts submitted during PCR London Valves 2022: one-year outcomes for transcatheter mitral repair from the MiCLASP study, the Edwards PASCAL transcatheter mitral valve repair system study, one-year outcomes of Tendyne TMVR treating symptomatic MR,...

Transcatheter mitral valve interventions: clinical outcomes 1

Rapid-fire abstracts: Session 5

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of abstracts presented during PCR LV 2022: impact of right ventricular dysfunction on the outcomes of TAVI - Insights from nationwide database, impact of COVID-19 pandemic on TAVI activity: a worldwide registry, redo isolated tricuspid valve surgery - Prediction of...

Rapid-fire abstracts: Session 5

The right valves for the right ventricle: Venus MedTech tricuspid and pulmonary replacement systems

27 Nov 2022 – From PCR London Valves 2022

In this session from PCR London Valves 2022, discover the new Venus MedTech technology for tricuspid and pulmonary valve replacement, and a review of the clinical indications, selection criteria and procedural details.

The right valves for the right ventricle: Venus MedTech tricuspid and pulmonary replacement systems

Therapy of valvular heart diseases: a patient-centred innovation journey

27 Nov 2022 – From PCR London Valves 2022

Join a team of experts as they review together the complete spectrum of valvular heart disease and ways in which we can manage it using emerging novel technologies.

Therapy of valvular heart

Primary mitral regurgitation: key imaging requirements for diagnosis and procedural planning

27 Nov 2022 – From PCR London Valves 2022

In this session, find out more about the most common types of primary mitral regurgitation and methods for their evaluation, the principal indications for intervention, as well as the available modes of therapy (surgical/transcatheter) and most appropriate choices for individual patients.

Primary mitral regurgitation: key imaging requirements for diagnosis and procedural planning

Reinventing the treatment of patients with tricuspid valve disease

28 Nov 2022 – From PCR London Valves 2022

This innovative session takes you through the patient selection and anatomical characteristics when selecting amongst the different transcatheter options to treat tricuspid regurgitation, followed by a recorded demonstration using the PASCAL Precision repair system.

Reinventing the treatment

The new PASCAL Precision system unleashes the full potential of mitral transcatheter edge-to-edge repair

28 Nov 2022 – From PCR London Valves 2022

Join this panel of experienced physicians to learn more about the novel PASCAL Precision system and to discuss implant selection and clinical data. Finally, participate in a recorded case demonstrating the use of the PASCAL Precision system for the treatment of mitral regurgitation.

The new PASCAL Precision

Twenty years of progress - What we have achieved - LIVE case

27 Nov 2022 – From PCR London Valves 2022

  • Part 1: TAVI by axillary access (Live)
    An 80-year-old female with peripheral arterial disease presents a symptomatic severe aortic stenosis with small annulus and preserved LV function.
    The operators implant, by axillary access, an Evolut pro 26 mm, on general anaesthesia, with predilatation (Balloon 18 mm) and post-dilatation...
Twenty years of progress - What we have achieved

TAVI-in-TAVI - A road map for successful lifetime management

29 Nov 2022 – From PCR London Valves 2022

Join a team of experts that guide you through the basics of TAVI-in-TAVI, the procedural planning and techniques of implantation, followed by case examples with different index prostheses.

TAVI-in-TAVI - A road

TAVI step by step: from femoral puncture to procedural success

27 Nov 2022 – From PCR London Valves 2022

Look at these presentations to get insights into the basics of CT evaluation for TAVI procedural planning, and discover how to optimise every aspect of the TAVI procedure and ensure the best clinical outcomes even in difficult anatomies. 

TAVI step by step: from femoral puncture to procedural success

Transcatheter mitral valve replacement - From planning to final assessment

27 Nov 2022 – From PCR London Valves 2022

In this session, a panel of experts share their experience with transcatheter mitral valve replacement and more specifically new planning and guidance tools using multiple imaging modalities.

Transcatheter mitral

Tricuspid valve interventions in heart failure patients - Treatment optimisation and pre-procedural work-up

27 Nov 2022 – From PCR London Valves 2022

Consult these presentations to learn more about tricuspid valve intervention in heart failure patients, to discover which patients are suitable candidates for this procedure and to appreciate the importance of imaging, haemodynamic assessment, optimised medical and heart rhythm treatment prior to this intervention.

Tricuspid valve interventions in heart failure patients - Treatment optimisation and pre-procedural work-up

HighLife TSMVR and their latest experiences, moving forward

29 Nov 2022 – From PCR London Valves 2022

A panel of experts review the latest clinical data, study progress and future plans regarding mitral valve replacement, and the position of HighLife, a new technology in this field.

HighLife TSMVR and their
Didn’t find what you were looking for?